Matrix is the site of indirect effects of propranolol on the ion channelopathies in cardiac remodeling by L-thyroxine

Journal of Cardiac Surgery

Volumn 17, Issue 5, 2001, Pages 439-446

  Dai, De Zai ^a   Wang, Hong Lan ^a   Zhang, Guang Qin ^a   He, Gou Xing ^a   Chen, Li ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ION CHANNEL; LEVOTHYROXINE; LIOTHYRONINE; LIPID; LIPID OXIDE; PROPRANOLOL; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CALCIUM CURRENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENERGY CONSUMPTION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; GUINEA PIG; HEART ARRHYTHMIA; HEART HYPERTROPHY; HEART MUSCLE POTENTIAL; HEART RATE; HEART VENTRICLE REMODELING; ION CURRENT; LIOTHYRONINE BLOOD LEVEL; LIPID MEMBRANE; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; QT INTERVAL; THYROXINE BLOOD LEVEL;

EID: 0036771275     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb01175.x     Document Type: Conference Paper

References (20)

1. Prior SG, Napolitano C, Paganini V, et al. Molecular biology of the long QT syndrome: Impact on management. Pace 1997;20:2052-2057.
2. Sanguinetti MC, Jiang C, Curran ME, et al. A mechanistic link between an inherited and acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel. Cell 1995;81:299-307.
3. Dai DZ. Disordered ion channels and antiarrhythmic agents. Pharm News 2001;8:52-57.
4. Dai DZ. Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy. Act Pharmacol Sin 2000;21:289-295.
5. Qin D, Zhang ZH, Caref EB, et al. Cellular and ionic basis of arrhythmias in postinfarct remodeled ventricular myocardium. Circ Res 1996;79:461-473.
6. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res 1996, 79:669-675.
7. Takimoto K, Li D, Hershman KM, et al. Decreased expression of Kv 4.2 and novel Kv 4.3 channel sub-unit mRNAs in ventricles of renovascular hypertensive rats. Circ Res 1997;533-539.
8. Yu F, Dai DZ, An LF, et al. Heart hypertrophy induced by levo-thyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats. Act Pharmacol Sin 18:71-74.
9. Miyazawa K, Hashimoto H, Uematsu T, et al. Electrophysiological abnormalities and enhanced reperfusion arrhythmia in the isolated hearts of hyperthyroid rats. Br J Pharmacol 1989;97:1093.
10. Dai DZ, An LF, Huang DY, et al. Orthogonal analysis of aggravating effects of α, β-agonists and leukocytes on reperfusion-induced arrhythmias and ventricular fibrillation in Langendorff's rat heart. Act Pharmacol Sin 1996;17:145-148.
11. Dai DZ, Hu HQ, Yang P, et al. The ion channelopathies and arrhythmogenesis in cardiac remodeling. Chin J Pathophysiol 2000;16:945-947.
12. Dai DZ, Hu HJ, Yang DM, et al. Chronic levothyroxine treatment is associated with ion channel abnormalities in cardiac and neuronal cells. Clin Exp Pharmacol Physiol 1999;26:819-821.
13. Ma YP, Hao XM, Zhang GQ, et al. Blocking effect of CPU 86017 on slowly activated rectifier potassium current in single ventricular myocytes of guinea pigs. J China Pharmaceut Univ 2000;31:121-125.
14. Guerra PG, Talajic M, Roy D, et al. Is there a future for the antiarrhythmic therapy? Drugs 1998;56:767-781.
15. Colastsy TJ. Antiarrhythmic agents: Where are we going? Pharm News 1995;2:17-23.
16. Van Gelder IC, Brugemann J, Crijns HJ. Current treatment recommendations in antiarrhythmic therapy. Drugs 1998;55:331-346.
17. 2+-ATPase activity elevation. Act Pharmacol Sin 1996;17:516-518.
18. Balke CW, Shorofsky SR. Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 1998;37:290-299.
19. Han J, Leem CH, So I, et al. Effects of thyroid hormone on the calcium current and isoprenaline-induced background current in rabbit ventricular myocytes. J Mol Cell Cardiol 1994;26:925-935.
20. + channel in the cardiac hypertrophied model induced by L-thyroxine. Act Med Grad 2000;13:213-215.